Sign up to save your podcasts
Or
Share Case Consult: Adverse Effect Monitoring, Management, and Mitigation During Targeted Therapy for BRAF-Mutant mCRC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Case Consult: Adverse Effect Monitoring, Management, and Mitigation During Targeted Therapy for BRAF-Mutant mCRC
Host: Fortunato Ciardiello, MD, PhD
Host: Jenny Seligmann, MBChB, PhD
This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.
View all episodes
By ReachMDHost: Fortunato Ciardiello, MD, PhD
Host: Jenny Seligmann, MBChB, PhD
This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and the management of treatment-related adverse events.